Yujia Zhu

机构：Zhejiang Chinese Medical University, Sun Yat-sen University, Western General Hospital, Edinburgh Cancer Research, Key Laboratory of Guangdong Province, Sun Yat-sen University Cancer Center, Hangzhou Medical College, State Key Laboratory of Oncology in South China, University of Edinburgh · ORCID：0000-0002-8523-0125

发表论文 77 篇 · 总被引 948 次 · h-index 18

代表论文

• The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study (2023 · BMC Cancer · 被引 39)
• Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab (2024 · Nature Communications · 被引 34)
• Loss of colonic fidelity enables multilineage plasticity and metastasis (2025 · Nature · 被引 30)
• Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma (2023 · Cancer Medicine · 被引 17)
• Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial (2025 · BMJ · 被引 9)
• Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trial (2024 · EClinicalMedicine · 被引 9)